Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Amortizatization of Intangibles: 2021-2025

Historic Amortizatization of Intangibles for Roivant Sciences (ROIV) over the last 3 years, with Sep 2025 value amounting to $9.8 million.

  • Roivant Sciences' Amortizatization of Intangibles fell 58.12% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.6 million, marking a year-over-year increase of 210.40%. This contributed to the annual value of $70.0 million for FY2025, which is 922.05% up from last year.
  • Roivant Sciences' Amortizatization of Intangibles amounted to $9.8 million in Q3 2025, which was down 11.20% from $11.1 million recorded in Q2 2025.
  • In the past 5 years, Roivant Sciences' Amortizatization of Intangibles registered a high of $54.3 million during Q4 2024, and its lowest value of $1.6 million during Q2 2024.
  • Its 3-year average for Amortizatization of Intangibles is $13.6 million, with a median of $7.4 million in 2023.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first skyrocketed by 1,282.96% in 2024, then plummeted by 58.12% in 2025.
  • Roivant Sciences' Amortizatization of Intangibles (Quarterly) stood at $5.4 million in 2021, then increased by 11.20% to $6.0 million in 2022, then dropped by 16.01% to $5.0 million in 2023, then surged by 975.97% to $54.3 million in 2024, then crashed by 58.12% to $9.8 million in 2025.
  • Its last three reported values are $9.8 million in Q3 2025, $11.1 million for Q2 2025, and $54.3 million during Q4 2024.